{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:25:10Z","timestamp":1787757910711,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>HELLP (hemolysis, elevated liver enzymes, low platelet count) syndrome occurs in about 0.5%\u20130.9% of all pregnancies, but its prevalence is higher in patients with severe preeclampsia, accounting for a substantial maternal and perinatal morbidity and mortality. According to the latest American Society for Apheresis guidelines, Therapeutic plasma exchange (TPE) performed for postpartum cases and antepartum HELLP syndrome cases fall in Categories III and IV, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>Retrospective analysis was done at our tertiary care center from January 2014 to June 2019 for patients diagnosed with HELLP syndrome. Clinical data for age, gestational age at the time of diagnosis, type of delivery, outcome of pregnancy, history of preeclampsia \/eclampsia, hemoglobin levels, AST, ALT, LDH, platelet counts, prothrombin time, activated partial thromboplastin time, international normalised ratio, complete blood count, was obtained from patients' electronic medical records. The TPE was initiated within 24 hrs of diagnosis. All TPE was done on Spectra Optia apheresis system (Terumo BCT, Inc, USA). Statistical testing was conducted with the statistical package for the social science system version SPSS 20.0 and R-3.2.0. Continuous variables were expressed as mean\u00b1SD and were compared between Pre and Post TPE records of patients by using the paired T test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Nine patients fulfilled the criteria of HELLP syndrome. Seven (77.8%) were diagnosed in the postpartum period and 2 (22.2%) during the second trimester. Out of the total nine patients, two patients (22.2%) recovered completely and were discharged on day 15 \u00b1 7 days, whereas 4 (44.4%) patients were discharged on day 21 \u00b1 7 days with the advice of hemodialysis. Two (22.2%) patients had an intrauterine death and were discharged 3\u20134 days after the demise. In all these patients (except one), the TPE was initiated within 24 h of the diagnosis. A significant increase in platelet count and decrease in the lactate dehydrogenase levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) was observed post TPE.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Our data showed that TPE improved the treatment outcome in patients with HELLP syndrome despite being a Category III and IV indication among postpartum and antenatal females, respectively. However, a timely diagnosis and management are of paramount importance for a favorable outcome. TPE needs to be performed within 24 h of the diagnosis postdelivery when the patient is not responsive to the usual therapies, especially in class I HELLP syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_176_20","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T02:43:12Z","timestamp":1653964992000},"page":"106-110","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic plasma exchange in HELLP syndrome"],"prefix":"10.4103","volume":"16","author":[{"given":"Mohit","family":"Chowdhry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva Prasad","family":"Gajulapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday Kumar","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20240830","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ajog.2005.02.113","article-title":"Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. 1982","volume":"193","author":"Weinstein","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R2-17-20240830","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2393-9-8","article-title":"The HELLP syndrome: Clinical issues and management. A review","volume":"9","author":"Haram","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"R3-17-20240830","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R4-17-20240830","first-page":"243","article-title":"Plasmapheresis: Lifesaving treatment in severe cases of HELLP syndrome","volume":"5","author":"Vafaeimanesh","year":"2014","journal-title":"Caspian J Intern Med"},{"key":"R5-17-20240830","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9378(96)70162-X","article-title":"Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome","volume":"175","author":"Audibert","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R6-17-20240830","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00006250-199011000-00001","article-title":"Pregnancy complicated by preeclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes, and low platelet count: How rapid is postpartum recovery?","volume":"76","author":"Martin","year":"1990","journal-title":"Obstet Gynecol"},{"key":"R7-17-20240830","first-page":"387","article-title":"The use of plasma exchange in a very early-onset and life-threatening, hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome: A case report","volume":"6","author":"Iannaccone","year":"2016","journal-title":"Gynecol Obstet (Sunnyvale"},{"key":"R8-17-20240830","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"R9-17-20240830","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/107602960501100211","article-title":"The role of plasma exchange in HELLP syndrome","volume":"11","author":"Eser","year":"2005","journal-title":"Clin Appl Thromb Hemost"},{"key":"R10-17-20240830","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.transci.2014.12.026","article-title":"A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange","volume":"52","author":"Erkurt","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"R11-17-20240830","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1471-0528.1993.tb15172.x","article-title":"The interrelationship of eclampsia, HELLP syndrome, and prematurity: Cofactors for significant maternal and perinatal risk","volume":"100","author":"Martin","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"R12-17-20240830","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The sixth special issue","volume":"28","author":"Schwartz","year":"2013","journal-title":"J Clin Apher"},{"key":"R13-17-20240830","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"R14-17-20240830","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.transci.2014.12.009","article-title":"Early identification of women with HELLP syndrome who need plasma exchange after delivery","volume":"52","author":"Simetka","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"R15-17-20240830","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0002-9378(99)70022-0","article-title":"The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification","volume":"180","author":"Martin","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R16-17-20240830","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13224-014-0645-x","article-title":"LDH (lactate dehydrogenase): A biochemical marker for the prediction of adverse outcomes in pre-eclampsia and eclampsia","volume":"66","author":"Dave","year":"2016","journal-title":"J Obstet Gynaecol India"},{"key":"R17-17-20240830","first-page":"99","article-title":"Plasma exchange therapy in HELLP syndrome: A single-center experience","volume":"17","author":"Bayraktaro\u011flu","year":"2006","journal-title":"Turk J Gastroenterol"},{"key":"R18-17-20240830","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0019-5049.108568","article-title":"Thrombocytopenia-associated multiple organ failure or severe haemolysis, elevated liver enzymes, low platelet count in a postpartum case","volume":"57","author":"Jagia","year":"2013","journal-title":"Indian J Anaesth"},{"key":"R19-17-20240830","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.ajog.2005.07.037","article-title":"Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: A double-blind, placebo-controlled, randomized clinical trial","volume":"193","author":"Fonseca","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R20-17-20240830","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0020-7292(97)00214-2","article-title":"Dexamethasone in the post-partum treatment of HELLP syndrome","volume":"59","author":"Vigil-De Gracia","year":"1997","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_176_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:57:14Z","timestamp":1787756234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_176_20"}},"subtitle":["A life savior"],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_176_20","relation":{},"ISSN":["0973-6247"],"issn-type":[{"value":"0973-6247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}